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Abstract
Background: Bone morphogenetic protein (BMP) signalling has emerged as a fundamental pathway in endothelial
cell biology and deregulation of this pathway is implicated in several vascular disorders. BMP signalling output in
endothelial cells is highly context- and dose-dependent. Phosphorylation of the BMP intracellular effectors, SMAD1/5/9,
is routinely used to monitor BMP signalling activity. To better understand the in vivo context-dependency of BMP-
SMAD signalling, we investigated differences in BMP-SMAD transcriptional activity in different vascular beds during
mouse embryonic and postnatal stages. For this, we used the BRE::gfp BMP signalling reporter mouse in which the BMP
response element (BRE) from the ID1-promotor, a SMAD1/5/9 target gene, drives the expression of GFP.
Results: A mosaic pattern of GFP was present in various angiogenic sprouting plexuses and in endocardium of cardiac
cushions and trabeculae in the heart. High calibre veins seemed to be more BRE::gfp transcriptionally active than
arteries, and ubiquitous activity was present in embryonic lymphatic vasculature. Postnatal lymphatic vessels showed
however only discrete micro-domains of transcriptional activity. Dynamic shifts in transcriptional activity were also
observed in the endocardium of the developing heart, with a general decrease in activity over time. Surprisingly,
proliferative endothelial cells were almost never GFP-positive. Patches of transcriptional activity seemed to correlate
with vasculature undergoing hemodynamic alterations.
Conclusion: The BRE::gfp mouse allows to investigate selective context-dependent aspects of BMP-SMAD signalling.
Our data reveals the highly dynamic nature of BMP-SMAD mediated transcriptional regulation in time and space
throughout the vascular tree, supporting that BMP-SMAD signalling can be a source of phenotypic diversity in some,
but not all, healthy endothelium. This knowledge can provide insight in vascular bed or organ-specific diseases and
phenotypic heterogeneity within an endothelial cell population.
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Background
The formation of the cardiovascular and lymphatic net-
work is crucial for development and physiology. The car-
diovascular system fuels nearly every tissue with oxygen
and nutrients and removes waste products, while the
lymphatic system is important for the drainage of extrav-
asated fluid, the uptake of fat and is a vital part of the
immune system [1]. Blood vessel development by
sprouting from pre-existing vessels is called sprouting
angiogenesis. In hypoxic environments angiogenic
sprouts with tip and stalk cells emerge. Sprouts anasto-
mose to form new functional vessels that supply oxygen
to the initially hypoxic environment [1]. From the car-
dinal vein some venous endothelial cells (ECs) differenti-
ate into lymphatic ECs (LECs), that migrate to form
lymphatic sacs which in turn sprout to form a lymphatic
network similar to angiogenesis events [2]. Failure to es-
tablish a (lymphatic) vascular network leads to severe
embryonic defects at mid-to late gestation, whereas mis-
regulation after birth can lead to diseases such as cancer,
chronic and inflammatory disorders and oedema [3–5].
ECs form the inner cellular lining of blood and lymph-
atic vessels and the heart, and differ in protein expres-
sion, morphology and function depending on the
vascular bed. Exposure to external and internal cues as
well as epigenetic programming results in EC macro-
heterogeneity and micro-heterogeneity [6–8]. This
means that the endothelium acquires site- and organ-
specific structural and functional properties, which are
extensively reviewed in Aird et al. [7–9].
BMP signalling has emerged as a fundamental pathway
of EC identity by regulating cardiovascular and lymph-
atic development [10]. BMPs are members of the trans-
forming growth factor beta (TGFβ) family with more
than 20 BMP members identified. BMP ligands reported
to function in ECs are BMP2/4/6/7/9/10 [11]. BMPs
bind to heteromeric transmembrane receptor complexes
that consist of type I (ALK1/2/3/6) and type II receptors
(BMPR2, ACTR2A, ACTR2B) and often also a co-
receptor (Endoglin, Betaglycan). Ligand binding and
phosphorylation of the GS-domain of the type I receptor
by the type II receptor leads to recruitment and phos-
phorylation of the intracellular effectors SMAD1,
SMAD5 and SMAD9 (pSMAD1/5/9) [12]. SMAD9 is
also known as SMAD8. Activated pSMADs form a com-
plex with the common SMAD, SMAD4, and translocate
to the nucleus where they stimulate transcription of spe-
cific BMP target genes such as the inhibitors of differenti-
ation (IDs), HEY1 and SMAD6/7; and repress e.g. Apelin
[13]. BMPs can also regulate other (non-canonical) path-
ways that do not involve SMAD proteins [14, 15].
BMP signalling is highly tuned by extracellular and
intracellular modulators, but also by signalling interplay
with other signalling pathways. Furthermore, BMPs are
known to trigger expression of different target genes in a
dose-dependent manner [16, 17], a landmark of morpho-
gens. In addition, hemodynamic changes can induce BMP
signalling and activate SMAD proteins in ECs [18, 19]. Re-
cently, excessive BMP6 has been implicated in cerebral
cavernous malformation [20]. Moreover, other regional-
ized vascular disorders such as hereditary hemorrhagic
telangiectasia (HHT) and pulmonary arterial hypertension
(PAH) are mainly caused by mutations in the BMP recep-
tors ACVRL1 (encoding ALK1) or ENG (encoding Endo-
glin) and BMPR2 respectively [21–24]. The question
remains how mutations in components of the same BMP
pathway can cause such organ-specific diseases. A better
understanding of the heterogeneity in BMP signalling out-
put in different vascular beds may provide this insight and
perhaps even the opportunity for disease-specific therapy.
Phosphorylated SMAD1/5/9 are routinely used to
monitor BMP transcriptional activity, however this may
confound interpretation, because pSMADs also play a
role in chromatin remodelling and miRNA biogenesis
[15]. To investigate the transcriptional activity of BMP-
SMAD signalling many BMP reporter mice have been
generated [25–30]. In this study we examined the
BRE::gfp reporter mouse in which BMP response ele-
ments (BRE), derived from the ID1-promotor, drive the
expression of enhanced green fluorescent protein (eGFP)
[25]. The substantial decrease in GFP levels observed in
Smad5-deficient BRE::gfp embryos corroborate the
BMP-SMAD sensitivity of this reporter [25]. A common-
ality between all BRE-based reporters is that BRE activity
does not completely overlap with pSMAD1/5/9 signal-
ling domains [26, 27, 29, 31] because the onset of re-
porter activity first requires de novo mRNA and protein
synthesis and GFP maturation, and the half-life of the re-
porter protein may deviate from pSMAD1/5/9 [29, 32, 33].
Moreover, pSMAD1/5/9 can also bind with different affin-
ities and regulate other DNA-sequences like e.g. MEME2
[34]; pSMAD1/5/9 also has non-transcriptional functions
[15]. Additionally, the BRE::gfp reporter is heterozygous,
and it is becoming apparent that gene expression in
general occurs with bursts of monoallelic expression
instead of constant biallelic expression [35, 36]. None-
theless, the relevance of the BRE::gfp reporter mouse
became apparent in our previous study. Discrete GFP
localisation patterns in angiogenic endothelium of
BRE::gfp embryos, with an otherwise widespread
pSMAD1/5/9 localisation, singled out those cells that
underwent ID-mediated BMP-SMAD and Notch co-
signalling essential for robust stalk cell fate [37].
In this study we aimed to further document regional
differences in BMP-SMAD dependent transcriptional ac-
tivity in murine endothelium of blood vessels, lymphatic
vessels and the heart at embryonic and postnatal stages.
We defined regions with stereotypic mosaic and
Beets et al. BMC Developmental Biology  (2016) 16:34 Page 2 of 16
continuous BRE::gfp localisation patterns, yet also GFP-
negative regions were found in areas where BMP-SMAD
signalling has been reported, compatible with the mor-
phogen functions of BMP ligands. Our data support that
BMP-SMAD signalling can play a role in phenotype
switching and endothelial cell heterogeneity.
Methods
Mice and tissue collection
BRE::gfp transgenic mice and endothelium-specific
Smad1;Smad5 knockout (Tie2cre+/0;Smad1fl/fl;Smad5fl/fl)
mice were used. Genotyping of transgenic mice was
done as described [25, 37]. All embryos and postnatal
organs were dissected in ice-cold diethylpyrocarbonate
(DEPC)-treated phosphate buffered saline (PBS) and
fixed overnight (ON) in 4 % paraformaldehyde (PFA) in
PBS at 4 °C. Afterwards they were rinsed with PBS and
saline and stored in 70 % ethanol until processing.
Fixed embryos of embryonic day (E) 9.5–12.5, E14.5
and E16.5 and P6 intestines were processed for paraffin
sectioning. Skin tissue from E14.5 and E16.5 BRE::gfp
embryos was dissected after fixation. Layers of muscle
and tissue were carefully removed from the skin, leaving
the superficial lymphatic network intact. From each em-
bryo two skin biopsies were harvested. Retinas were col-
lected from fixed eyes by removing the cornea and
carefully lifting the retina from the remaining eyeball.
Ears were collected from postnatal pups and separated
into a ventral and dorsal side of which the latter was
analysed. For each analysis a minimum of three animals
was examined.
Immunofluorescence
Whole mount procedure
Embryos, skin biopsies, retinas, mesentery and ear skins
were rehydrated and blocked in 2 % bovine serum albu-
min (BSA) in Tris buffered saline (TBS) for 3 h at room
temperature (RT). Tissues were incubated ON with pri-
mary antibodies in 2 % BSA in TBS at 4 °C, except for
the embryos which were kept at RT. This was followed
by blocking for 3 h in 2 % BSA in TBS and incubation
with the secondary antibody ON (Alexa antibodies,
Jackson Immunology). The list of primary antibodies
and the used dilutions are provided in supplementary
material (Additional file 1: Table S1).
After whole mount immunostaining of E9.5 (22 ± 2 so-
mites) and E10 (30 ± 2 somites) embryos the forebrain
and the abdomen caudally from the forelimb bud were
transversally removed. All ventral tissues including the
heart were removed and the neural tube was then cut
open at the ventral side. The hindbrain was mounted on
a glass slide with the ventral side facing up.
The mesentery was excised from the intestines after
whole mount immunostaining, and the retina was cut
into a four-leaf clover before mounting on a glass
slide.
Paraffin sections
Transversal and sagittal sections (6–8 μm) of paraffin
embedded tissues were processed for immunodetection
using an automated platform (Ventana Discovery Ultra,
Roche). Immunofluorescent triple detection of
pSMAD1/5/9, GFP and MF20 was done manually. The
list of primary antibodies, as well as the conditions used,
are provided in supplementary material. Antigen re-
trieval was done by submerging the slides in Tris-EDTA
buffer (10 mM Tris Base, 1 mM EDTA, 0.01 % Tween20,
pH9.0) for 30 min at 96 °C. For pSMAD1/5/9, endogen-
ous peroxidases were inactivated in 3%H2O2 in Metha-
nol for 30 min and the antibody signal was amplified
using the Perkin Elmer TSA Biotin system kit
(NEL700A001KT).
In situ hybridisation
Embryos were dissected in DEPC-treated PBS and fixed
ON in 4 % PFA in PBS at 4 °C. Afterwards they were
washed three times 30 min in DEPC-treated PBS,
immersed in 15 % sucrose and snap frozen in Optimal
Cutting Temperature (OCT) compound (Richard-Allan
Scientific #6502) with liquid nitrogen. The GFP fluores-
cent in situ hybridisation (ISH) probe was custom de-
signed with the probe designer tool from Stellaris (LGC
biosearch technologies). The coding sequence of the
pEGFP-N2 plasmid (accession number U57608.1) was
used for probe design.
Fluorescent ISH (FISH) was performed according to
the manufacturer’s protocol (Stellaris) with the
addition of a permeabilisation step with 1 % Tri-
tonX100 (Sigma T8787) in PBS. Images were acquired
using a Nikon A1R Eclipse Ti confocal microscope.
Results
Co-localisation of BRE::gfp transcriptional activity and GFP
in endothelium
To study BMP transcriptional activity in vessel devel-
opment, we used the previously generated BRE::gfp
reporter strain [25]. We took advantage of the un-
stable nature of gfp mRNA, the sensitivity and single
cell resolution of in situ hybridisation (ISH) on the
one hand and the direct co-observation of GFP fluor-
escence on the other hand to validate whether GFP
protein localisation reflects well the BRE::gfp tran-
scriptional activity in endothelium. We show that
there is a near to absolute correlation between the
gfp mRNA expression and direct GFP fluorescence lo-
calisation in vascular beds like e.g. the cardinal vein
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(Fig. 1a–d). In other endothelial linings such as in the
heart ventricles there is a good overlap between mRNA
and protein, yet a fraction of the cells express only gfp
mRNA or only GFP protein. This is indicative of onset of
transcriptional activity while GFP protein translation and
maturation is still taking off in the former cells, while tran-
scriptional activity has already terminated but GFP protein
is still present in the latter cells (Fig. 1e–g). This pattern
suggests the dynamic turning “on” and “off” of transcrip-
tional activity. Overall, we conclude that GFP protein pat-
terns report with fidelity BRE::gfp transcriptional activity
patterns.
The GFP localisation pattern is mostly a subdomain of
the pSMAD1/5/9 pattern (Additional file 2: Figure S1A-B)
as previously reported [31], which is compatible with
BMP-SMAD non-transcriptional and morphogen func-
tions as discussed in the background section of this paper.
The specificity of the anti-pSMAD1/5/9 antibody was
validated in endothelium-specific Smad1;Smad5 double
knockout embryos (Additional file 2: Figure S1D-E). How-
ever, in some endothelial beds like e.g. in the cardinal vein
in E11.5 embryos, GFP localisation hardly overlapped with
pSMAD1/5/9 localisation (Additional file 2: Figure S1C),
suggesting terminated or undetectable pSMAD1/5/9
signalling or transcriptional activation of the BRE:gfp
transgene by other factors than BMP signalling.
BRE::gfp transcriptional activity is present in a mosaic
pattern during embryonic angiogenesis
To closely examine BRE::gfp transcriptional activity in
the rapidly expanding vascular plexus, we analysed em-
bryonic day (E) 9.5 (22 somites) and E10 (30 somites)
BRE::gfp mouse embryos. Tip and stalk cell formation as
well as anastomosis during sprouting angiogenesis can
then be investigated. In the roof of the hindbrain sprouts
are formed from the perineural vascular plexus at op-
posite lateral sides of the embryo that then anastomose
medially in a caudal fashion from the level of the otic
vesicles onwards [37].
Whole mount immunostainings of BRE::gfp embryos
showed that GFP was mainly present in and around the
heart region at 22 somites (s), with little BRE::gfp tran-
scriptional activity in the Endomucin-positive blood ves-
sels (Fig. 2a–c). However, in 30s embryos a scattered
GFP pattern co-localised particularly within the main
vessels of e.g. the head and the intersomitic vessels
(Fig. 2d–f ). The hindbrain roof was excised from these
embryos and the dorsal vascular plexus was flat-
Fig. 1 The GFP reporter protein faithfully recapitulates the transcriptional activation of the BRE::gfp transgene. In situ hybridisation for gfp mRNA
(red) and direct GFP fluorescence (green) on cryosections through the cardinal vein (a–d) and the ventricular trabeculae (e–g) at E11.5. DAPI is
used to stain nuclei. The boxed area in (a) is enlarged in panels (b–d). The corresponding low magnification view of the trabeculae in the
ventricle is not provided because of insufficient intensity of the ISH signal. White arrowheads indicate ECs double positive for gfp mRNA and
direct GFP fluorescence. The red and green arrows depict ECs only positive for gfp mRNA or GFP fluorescence respectively. Scale bars: 100 μm (a);
50 μm (b–d); 10 μm (e–g)
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mounted (Fig. 2g, top panel) [37]. In the two-
dimensional vascular plexus at 22 s BRE::gfp transcrip-
tional activity occurs in a scattered or mosaic pattern
throughout the plexus, which is in accordance with pre-
vious observations [37]. Remarkably, some tip cells were
found to express low levels of GFP while the mosaic pat-
tern in non-tip cells was more intense throughout the
plexus (Fig. 2g, bottom panels). This is in contrast with
earlier observations where GFP was not detected in tip
cells [37], which likely reflects higher affinity of the
current chicken polyclonal anti-GFP antibody than the
previously used mouse monoclonal anti-GFP antibody.
At E9.75 the vessels from the superficial vascular plexus
start to invade the hindbrain, thus forming a multi-
layered vascular network [38]. Depth coding of the dor-
sal hindbrain region at 30s revealed the superficial and
deeper plexus (Fig. 2h). The latter had slender vessels
with slim tip cells, whereas the superficial plexus had
thicker honeycomb-like vessels and broader tip cells, as
seen at 22 s (Fig. 2g–j). The GFP localisation pattern in
both plexuses was mosaic and comparable to the plexus
of the 22 s embryo, yet, the deeper plexus seemed to be
enriched in GFP-positive ECs (Fig. 2j) compared to the
superficial plexus (Fig. 2i). Additionally, a string of GFP-
positive non-endothelial cells was observed in the mid-
line at both stages. This correlates with the presence of
BMP6 and BMP7 in the dorsal midline at E9.5-E10.5
[39, 40]. In general, the two distinct dorsal vascular plex-
uses demonstrate heterogeneity in BMP-SMAD signal-
ling in an angiogenic vascular bed.
Spatio-temporal changes in BRE::gfp activity during
retinal angiogenesis
The retina is commonly used to investigate postnatal
blood vessel development. The primary plexus develops
from the optic nerve towards the peripheral margin.
Around postnatal day (P) 5 the primary vascular plexus
invades the deeper retinal layers perpendicularly where-
after the outer plexus forms again radially. Different as-
pects of vessel formation can be studied because
a b c
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Fig. 2 Mosaic BRE::gfp transcriptional activity in midgestation mouse hindbrain vasculature. Immunodetection of Endomucin and GFP in BRE::gfp
embryos of 22 s (a–c) and 30s (d–f). Arrowheads indicate the heart region. Boxed areas represent the head region (b, e) and the intersomitic
vessels (c, f). g Overview of a 22 s dorsal vascular plexus (Endomucin and GFP) in a flat-mounted hindbrain roof. Arrows indicate direction of rostral
(R) to the left, caudal (C) to the right. Boxed areas (bottom panels) show sprouts at the midline. Asterisks depict GFP-positive tip cells. h Depth cod-
ing of a 30s dorsal vascular plexus and the original picture (right panel). Blue and green colours represent more ventral and dorsal tissues respect-
ively. The vascular plexus at 30s consists of a superficial (i) and deeper plexus (j). Boxed areas are enlarged in the right panels. Scale bars: 500 μm
(a; d); 100 μm (b–c; e–f); 75 μm (g, top; h; i–j, left panels); 50 μm (i–j, right panels); 25 μm (g, bottom)
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vascular sprouting happens at the periphery while re-
modelling occurs simultaneously in the centre [41, 42].
The GFP localisation pattern was diverse but stereo-
typic throughout the retinal stages investigated and the
GFP levels decreased over time. At P4, the vasculature
has sprouted halfway across the retina (Fig. 3a). The
sprouting front displayed relatively strong GFP signals
compared to the central plexus (Fig. 3b–c). Many tip
cells at the sprouting front as well as the arteries and
veins in the centre were GFP-positive, whereas the inter-
mediate capillary bed displayed a more mosaic GFP dis-
tribution (Fig. 3b–c). Moreover, arteries seemed weaker
GFP-positive compared to the strong GFP-positive veins
(Fig. 3c). At P8 the sprouting front developed into a vas-
cular border. Comparable to P4, GFP-positive arteries
and veins were observed, along with a mosaic distribu-
tion of GFP in the capillaries (Fig. 3d–e). At this stage
the matured vessels in the centre have sprouted into the
retina to form the perpendicular vessels and the outer
plexus. Approximately half of the perpendicular vessels
seemed GFP-positive, though weaker than the veins of
the primary plexus (Fig. 3e–f ). Moreover, the less rami-
fied outer plexus also displayed a mosaic GFP pattern
(Fig. 3g). Overall, fewer GFP-positive cells were present
in the different plexuses at P10, although the mosaic dis-
tribution was maintained in the primary and outer
plexus (Additional file 3: Figure S2). These data indicate
a dynamic nature of BMP-SMAD signalling over time.
GFP localisation patterns are dynamic in the developing
heart
Given the well-known functions of BMPs in heart devel-
opment and the presence of BRE::gfp activity during
early heart development and valve formation [25], we
zoomed in deeper on the spatio-temporal patterns of
BRE::gfp transcriptional activity in endocardium at E9.5-
E12.5, E14.5 and E16.5 and observed remarkable re-
gional differences over time. At E8.0 the initial heart
tube starts to loop and progressively forms the four
chambered heart [43, 44]. The heart tube comprises an
a d e
b c f g
Fig. 3 Different BRE::gfp transcriptional activity patterns in the postnatal vasculature. a Overview of a P4 retina with immunodetection of
Endomucin and GFP. Boxed areas show the sprouting front (b) and the centre (c) of the retinal plexus. Single staining for GFP is shown in the
bottom panels. Asterisks depict GFP-positive tip cells, the arrows point to the veins, while the arrowheads show the arteries. d–g The retina at P8,
immunostained for Endomucin and GFP, has a multi-layered vascular plexus consisting of the vascular border (d) and centre (e) of the primary
plexus, the perpendicular vessels (f) and outer plexus (g). Single GFP staining is shown in the lower panels. Scale bars: 500 μm (a); 75 μm (b–g)
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inner endothelial layer and an outer myocardial layer
separated by extracellular matrix or cardiac jelly [45].
The pro-epicardial organ progressively covers the myo-
cardial layer with epicardium. Overall, relatively few
GFP-positive cells were observed in tissue sections of
the developing heart (Fig. 4), which is consistent with
former results [25]. Nonetheless, GFP patterns were ro-
bust and reproducible in endocardial subregions, and
changed over time (Additional file 4: Table S2).
Cardiac cushions are the primordia of the valves and
most septa in the developing heart. They are formed in
the atrioventricular canal (AVC) which separates the
atria from the ventricles and the outflow tract (OFT)
which bridges the ventricles with the aortic sac [43–45].
At respectively E9.5 and E10.5 the endocardial cells of
the AVC cushions and proximal OFT cushions delamin-
ate, undergo endothelial-to-mesenchymal transition
(EndMT) and invade the cardiac jelly [43–45]. In con-
trast, the distal OFT cushions become mainly populated
by neural crest cell derived mesenchymal cells from
E10.5 onwards [46].
The endocardial cells of the superior and inferior AVC
cushions displayed a mosaic GFP localisation pattern
until E11.5 (Fig. 4a–c). From E12.5 onwards, patches of
a
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Fig. 4 Dynamic BRE::gfp transcriptional activity in the developing heart. Paraffin embedded hearts are sectioned transversally, unless otherwise
specified, and (immuno) stained for the endothelial marker IsolectinB4 and GFP. DAPI is used to stain nuclei. a Overview of an E11.5 heart. b Section of
the superior and inferior atrioventricular canal cushions at E11.5. c E11.5 sagittal section of AVC (arrow) and OFT cushions (arrowhead). d E11.5 lateral
cushion with GFP-positive endocardial cells (arrow) and myocardium (arrowhead). e At E11.5 the septum primum displays GFP-positive ECs on the
endothelial cap (bracket). The atrium is GFP-negative at E11.5 (f) while the ventricular trabeculae (g) have GFP-positive ECs (arrows). h Overview of an
E14.5 heart. The tricuspid valve shows GFP-positive cells at the atrial side (arrows) at E14.5 (i) and E16.5 (j). GFP signals (arrows) in the intra-atrial septum
at E14.5 (k) and E16.5 (l). Some endocardial cells covering the atrial (m) and ventricular trabeculae (n) are GFP-positive (arrows) at E14.5. Ao: aorta; AVC:
atrioventricular canal; iAVC: inferior AVC cushion; sAVC: superior AVC cushion; BV: bicuspid valve; CV: cardinal vein; dOFT: distal outflow tract; IVS: inter-
ventricular septum; LA: left atrium; LV: left ventricle; pOFT: proximal outflow tract; RA: right atrium; RV: right ventricle; SP: septum primum; TV: tricuspid
valve. Scale bars: 200 μm (a;h); 100 μm (c, i-j); 50 μm (b, d-g, k-n)
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GFP-positive ECs were restricted to the atrial side of the
superior cushion. These streaks of GFP-positive ECs
remained present at E14.5 and E16.5 on the medial leaf-
lets of the tricuspid and bicuspid valve that form from
these cushions (Fig. 4h–j). In contrast, only few GFP-
positive ECs were present in the lateral AVC cushions
from E11.5 onwards (Fig. 4d; i). Yet, at E16.5 the lateral
leaflets of the tricuspid and bicuspid valve displayed, just
like the medial leaflets, also patches of GFP-positive ECs
(Fig. 4j). Patches of GFP-positive muscle cells were also
observed in the AVC myocardium flanking the develop-
ing cushions and valves up to E14.5, though with varying
GFP levels among neighbouring cells. (Fig. 4d; h–i). The
ECs of the OFT cushions showed a mosaic GFP localisa-
tion pattern comparable to the AVC cushions at E11.5,
although the OFT appeared slightly enriched in GFP-
positive ECs (Fig. 4c). Remarkably, the mesenchymal
cells that populate the AVC and OFT cushions were
GFP-negative (Fig. 4a–c). In contrast to the ECs of the
AVC and OFT, the ECs of the inflow tract and the endo-
thelial cap of the septum primum showed a ubiquitous
GFP localisation pattern at E11.5 (Fig. 4e and Additional
file 5: Figure S3A). As development proceeds and this
septum reaches the superior cushion forming the intra-
atrial septum, BRE::gfp transcriptional activity decreased
with only a few GFP-positive ECs still present at E14.5
and E16.5 (Fig. 4k–l).
Only occasionally a GFP-positive cell was detected in
atrial endothelium at E11.5 (Fig. 4f ), while the ventricles
showed a mosaic GFP pattern in the ECs covering the
trabeculae throughout the stages analysed (Fig. 1e–g,
Fig. 4g). Interestingly, a mosaic pattern also emerged in
the atrial endothelium coinciding with initiation of tra-
beculation from E12.5 onwards (Fig. 4m–n). Moreover,
the ECs of the aortic and pulmonary valve leaflets also
displayed a mosaic GFP pattern at E14.5 (Additional file
5: Figure S3B–C).
Levels of BRE::gfp activity differ in embryonic and
postnatal blood and lymphatic vessels
Little information is available on BMP-SMAD signalling
in different lymphatic beds. At E9.75 the first LECs differ-
entiate from venous ECs in the cardinal vein [1]. These
LECs bud of, migrate and assemble into lymphatic sacs by
E11.5, which will remodel into a functional lymphatic net-
work. We found interesting spatio-temporal differences in
BRE::gfp transcriptional activity during lymphangiogenesis.
In the embryo most blood and lymphatic vessels have a
widespread GFP localisation pattern, while in postnatal
tissues like the mesentery, intestinal villi and the ear skin
many blood vessels appeared to have reduced GFP signals
and the lymphatic vessels had discrete and unique GFP lo-
calisation patterns.
In general, the blood vessels, including the cardinal
vein, and lymphatic vessels displayed a continuous GFP
localisation pattern at E11.5-E14.5 (Fig. 1a-d, Fig. 4a,
Additional file 6: Figure S4A-B). However, the aorta
showed a mosaic GFP localisation pattern (Fig. 4a).
Interestingly, nearly all PROX1- positive LECs budding
from the cardinal vein were GFP-positive, yet still weakly
positive for the blood vessel marker Endomucin in E10.5
embryos (Fig. 5a). Likewise, at E12.5 some GFP-positive
ECs were PROX1- and Endomucin-positive (Fig. 5b), yet
in few sections at E14.5 the GFP-positive cardinal vein
adjacent to the lymphatic sac was Endomucin-positive
on the medial side, while the lateral side, closest to the
lymphatic sac, was PROX1-positive (Fig. 5c). Blood and
lymphatic vessels in dorsal skin biopsies were also ubi-
quitously GFP-positive at E14.5 and E16.5 (Fig. 5d–e
and Additional file 6: Figure S4C). However, the GFP
signal appeared more uniform in the blood vessels,
whereas the LECs showed different levels of GFP among
neighbouring cells (Fig. 5d–e). Other GFP-positive cord-
like structures were observed at E14.5 and E16.5 in
dorsal skin biopsies, but these were excluded as vessels
because they were Collagen Type IV-negative
(Additional file 7: Figure S5). Similar structures have
been described as Schwann cells of sensory nerves [47].
Since the lymphatic network is still expanding after
birth, we investigated the postnatal mesentery, intestines
and ear skin. Different types of lymphatic vessels occur
in each of these tissues. The mesentery contains collect-
ing vessels, while lacteals resorb lipids from the intes-
tines and lymphatic capillaries drain lymph from ear
tissue.
Interestingly, many venous ECs appeared GFP-positive
in P4 and P6 mesentery (Fig. 6a–b), whereas only few
GFP-positive arterial ECs were observed (Fig. 6a–b) with
also some GFP-positive peri-endothelial cells covering
the arteries (Fig. 6b). The developing lymphatic vessels
were predominantly GFP-negative, although BRE::gfp
transcriptional activity was specifically present in some
valve forming regions (Fig. 6b). At P10, the arterial ECs
and peri-endothelial cells appeared GFP-negative and
also fewer venous ECs were GFP-positive, whereas the
lymphatic vessels still showed GFP in the valve regions
(Fig. 6c). Remarkably, the vessels had reduced BRE::gfp
transcriptional activity over time from P4 to P10
(Fig. 6a–c).
Most intestinal villi comprise a LYVE1-positive lymph-
atic vessel, called the lacteal, which is surrounded by an
Endomucin-positive blood capillary. Only few ECs of the
blood capillaries and lacteals were GFP-positive
(Fig. 6d–e). Other non-endothelial cells, such as goblet
cells, were also GFP-positive in the villus (Fig. 6d–e). In
the ear skin BRE::gfp transcriptional activity was absent
from the lymphatic capillary bed at P6 and P10, with the
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exception of a single GFP-positive LEC at some branch
points (Fig. 6f–i).
BRE::gfp transcriptional activity does not correlate with
proliferation
Inhibitors of differentiation or IDs are helix-loop-helix
proteins that interact with and inhibit basic helix-
loop-helix transcription factors. Through induction of
these IDs, the BMP pathway promotes EC migration
and tube formation [48]. This led to the hypothesis
that GFP-positive ECs would be proliferative. Several
embryonic and postnatal tissues were investigated for
co-localisation of GFP and phospho histone 3 (pH3)
in the blood and lymphatic system. PH3 is only
present in the M-phase of the cell cycle [49]. There
was rarely overlap between pH3 and GFP-positive
blood or lymphatic ECs in the neck region at E12.5
and E14.5 (Fig. 7a–d) or in dorsal skin biopsies from
E14.5 and E16.5 embryos (Fig. 7e–h). When pH3
seemed to be present in a GFP-positive EC, the pro-
liferating cell was usually not in the same focal plane
as the EC (Additional file 8: Figure S6A), or showed
mainly low to no levels of GFP (data not shown). In
addition, skin biopsies of E14.5 and E16.5 embryos
were immunostained for Ki67 which marks all active
phases of the cell cycle. Proliferation decreased
between E14.5 and E16.5, but even though many
non-endothelial cells were proliferative only few GFP-
positive ECs and LECs were Ki67-positive (Additional
file 8: Figure S6B-C). Also in the heart there was al-
most no co-localisation observed between pH3 and
GFP (Fig. 7i). Furthermore, ECs of the sprouting front
and the centre of the retina were not pH3-positive at
P3, however, at this stage non-endothelial cells were
more proliferative at the sprouting front than at the
centre (Fig. 7j). Overall, proliferation decreased by P8
but shifted towards the ECs, as now pH3-positive ECs
could be observed (Fig. 7k). Some of these proliferat-
ing cells seemed more GFP-positive than others. This
is an intriguing difference in co-localisation pattern
which suggests another context dependent role for
BMP-SMAD signalling.
a
b
c
d
e
Fig. 5 Spatio-temporal changes in BRE::gfp transcriptional activity in blood and lymphatic vessels. a–c Transverse sections at the level of the neck
of E10.5 (a), E12.5 (b) and E14.5 (c) BRE::gfp embryos with immunodetection of GFP, the blood vessel marker Endomucin and the lymphatic vessel
marker PROX1. DAPI is used to stain nuclei. Boxed areas are enlarged in the right panels, with single GFP, Endomucin and PROX1 staining next to
it. Skin biopsies of E14.5 (d) and E16.5 (e) BRE::gfp embryos with immunodetection of GFP, Endomucin and PROX1. Boxed areas are shown in the
middle (and right) panels with single staining for GFP in the right panel. CV: cardinal vein; DA: dorsal aorta; LS: lymphatic sac. Scale bars: 75 μm
(d–e, left panels); 50 μm (a–c, left panels; d–e, right panels); 25 μm (a–c, right panels)
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Discussion
Spatio-temporal information on output of important sig-
nalling pathways in the vasculature may help to increase
our understanding of how mutations in components of
the same pathway can cause organ-specific vascular dis-
orders and provide a window of opportunity for design-
ing disease-specific therapy. In the past decade, many
BRE-reporters have been generated in zebrafish and
mice [25–30]. The BRE::gfp reporter used in this study is
not the most sensitive, as some other BMP reporters
show broader patterns of transcriptional activity. How-
ever, this precisely allows to zoom in on selective pro-
cesses and dose-dependent BMP actions. Our study
shows that GFP patterns in endothelium faithfully report
transcriptional activation of the BRE::gfp transgene, and
are remarkably robust. However the BMP-SMAD tran-
scriptional output is highly dynamic in time and space,
in the different cardiovascular and lymphatic beds of
BRE::gfp mice.
Mosaic GFP localisation patterns were observed in dif-
ferent regions of the developing vascular tree and heart. It
was found in the dorsal vascular plexuses of midgestation
mouse embryos and in the capillary bed of P4-P10 retinas.
In addition, at E9.5-E11.5 the endocardial cells of the AVC
and OFTcushions and those lining the atrial and ventricu-
lar trabeculae also displayed a mosaic GFP pattern
(Additional file 5: Table S2). Such a mosaic pattern of
transcriptional activity suggests a role for BMP-SMAD in
EC plasticity and micro-heterogeneity. The multi-layered
vascular network of the dorsal hindbrain and retina de-
velop in a similar fashion, with the deeper plexus of the
dorsal hindbrain resembling morphologically more the ca-
pillary network in the primary plexus of the retina [38].
Previously, we showed that the BRE::gfp pattern singled
out stalk cell competent cells in the dorsal vascular plexus
that were undergoing BMP and Notch co-signalling and
that loss of BMP-SMAD signalling in endothelium re-
sulted in a stalk cell defect [37]. We also observed weak
GFP-positive tip cells in the dorsal hindbrain and retinal
plexuses. These tip cells might have been former stalk
cells that have taken over the tip cell position [50], with
traces of non-degraded GFP. Alternatively, BMP6 and
BMP7 synthesized by cells at the midline [39, 40] may
function as pro-angiogenic guidance cues that trigger an
a
f g h
i
b d
c e
Fig. 6 BRE::gfp transcriptional activity in postnatal blood and lymphatic vessels. a Stitch of a P4 mesentery with immunodetection of GFP and the
pan-endothelial marker CD31. Arteries, veins and collecting lymphatic vessels in a P6 (b) and P10 (c) mesentery are depicted. Arrows point to
GFP-positive peri-endothelial cells. Arrowheads show GFP-positive ECs in the vicinity of a valve. Sections of P6 intestines with immunodetection of
GFP and Endomucin (d) or the lymphatic vessel marker LYVE1 (e). White arrows point to some GFP-positive cells in a capillary, yellow arrows show
GFP-positive LECs in a lacteal. Arrowheads show some GFP-positive goblet cells. Stitch of P6 (f) and P10 (g) dorsal ear skin with immunodetection of GFP
and the lymphatic marker Podoplanin. GFP-positive LECs at the branch points are depicted by arrows at P6 (h) and P10 (i). A: artery; L: lymphatic vessel; V:
vein. Scale bars: 1 mm (a); 500 μm (f–g); 75 μm (b–e; h–i)
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alternative BMP-SMAD signalling pathway in the tip cells.
Circulatory BMP9 is likely to promote stalk cell compe-
tence through activating the mosaic transcriptional activ-
ity observed in the rest of the dorsal vascular plexus. In
the retina, BMP9 and BMP10 are important for postnatal
vascular remodelling [51]. Remarkably, BMP10 was un-
able to induce BRE activity in vitro, suggesting that the
GFP signals in the centre of the retina, where vessel
a c e
b
g i
e
f
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d
Fig. 7 BRE::gfp transcriptionally active ECs are rarely proliferative. Transverse sections of E12.5 (a, c) and E14.5 (b, d) BRE::gfp mouse embryos with
immunodetection of the proliferation marker (pH3), GFP and Endomucin (a–b) or PROX1 (c–d). Dorsal skin biopsies obtained from E14.5 (e, g)
and E16.5 (f, h) BRE::gfp embryos show pH3, GFP and Endomucin (e–f) or PROX1 (g–h) staining. Boxed areas are enlarged in the right panels. i
Overview of an E11.5 heart with immunodetection of GFP and pH3. DAPI is used to stain nuclei. The sprouting front (left panels) and centre (right
panels) of P3 (j) and P8 (k) retinas with immunodetection of GFP, Endomucin and pH3. Arrows point to pH3-positive ECs. AVC: atrioventricular
canal; IVS: inter-ventricular septum; LA: left atrium; LV; left ventricle; RA: right atrium; RV: right ventricle. Scale bars: 100 μm (i); 75 μm (e–h, left
panels; j–k); 50 μm; 25 μm (right panels)
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maturation and remodelling occurs, were the result of
BMP9 signalling. However, also BMP2, 4, 6 and 7 have
been shown to play significant roles in retinal neurogen-
esis and vascularisation [52]. Retinal vascularisation is pre-
ceded and stimulated by the development of a vast
network of neuronal cells [53], the latter also depending
on BMP-SMAD signalling [52, 54]. The retinal ECs recip-
rocally promote differentiation of the neuronal plexus
[53]. Our data do not allow to distinguish the precise
source and type of BMP signal, yet, BMP-SMAD tran-
scriptional activity seems more imperative at the sprouting
front than in the centre where the vascular plexus is
maturing.
Many BMPs have been reported to regulate cardiac
cushion development [43, 45]. In the AVC cushions,
BMP2 stimulates ECs to undergo EndMT [55], while
BMP4 is important in the OFT for proliferation and
growth of endocardial cushions rather than EndMT [56].
Studies with knockout mice reveal that BMP2, ALK2,
ALK3, BMPR2, SMAD4 and SMAD6 are important for
the development of the AVC cushions and to a lesser ex-
tent OFT cushions [55, 57–64]. Our study shows that
BMP signalling induces mosaic transcriptional activity in
cushion endocardium, likely to maintain an intact cushion
epithelium while a few cells can undergo EndMT.
Whether the GFP-positive cells or rather their neighbours
are subsequently triggered to undergo EndMT remains to
be elucidated. Taken together, in cushion endocardium
and in angiogenic endothelium, the mosaic-perhaps
stochastic-transcriptional BMP-SMAD activity seems to
serve as a source of phenotypic diversity. The exquisite
fine-tuning of the BMP pathway, which also involves
negative feedback mechanisms, may also generate switch
modes of activation states. Whether the mosaicism in
BMP-SMAD transcriptional activity is static or dynamic,
with BRE::gfp activity switching between ‘on’ and ‘off ’
states, cannot be addressed directly in our model due to
limitations in the resolution of real-time intravital micros-
copy, combined with the need for potentially long win-
dows of observation. Dynamic mosaicism in expression
has recently been demonstrated for von Willebrand factor
(VWF), and also in vitro for ESM1 and ephrin-B2, in some
but not all vascular beds. This appears to be a phenotype
switching strategy for adaptive homeostasis [65].
Remarkably, the endocardial cells of the atria turned
on mosaic BRE::gfp activity several days later than the
ventricular endocardial cells. Interestingly, this delayed
activation correlated with the delayed onset of BMP10
expression [66] and initiation of trabeculation in atrial
myocardium at E12.5 compared to the onset of the same
process in ventricular myocardium already at E9.5.
BMP10 is a well-known regulator of cardiac trabecula-
tion and/or compaction [67]. Trabeculation defects are
also observed in endothelium-specific Smad4 KO and
Smad1/Smad5 double KO embryos [37, 68]. Our data
suggest that not all ECs are equally involved in this
process. It would be interesting to evaluate whether and
how expansion from a mosaic to a continuous BMP-
SMAD transcriptional activity pattern in ventricular and
atrial endocardium would impact trabeculation or pro-
vide (fitness) advantages.
Remarkably, during embryonic development the
lymphatic vessels showed widespread BRE::gfp transcrip-
tional activity, yet in pups GFP-positive ECs were re-
stricted to the valve forming regions of collecting
lymphatic vessels in the mesentery. This is in agreement
with the role of BMP9 in lymphatic valve development
[69]. In the lymphatic capillary bed of the ear skin, an
occasional GFP-positive cell would localise at branch
points. Furthermore, GFP-positive endocardial cells were
observed on the atrial side of the tricuspid and bicuspid
heart valve leaflets, but also in the inflow tract. All these
patterns correspond with endothelium undergoing fluid
shear stress, which can induce BMP-SMAD signalling.
Hemodynamic alterations have been reported to induce
BMP4 and activate SMAD1/5 in the aorta [18, 70, 71],
and to mediate arteriogenesis [19].
Mature ECs are characterized by a slow proliferation
rate. For example, in adult ear skin only 0.2 % of the
LECs are reported to be Ki67-positive, whereas approxi-
mately 30 % of LECs are Ki67-positive in embryonic skin
at E16.5-E17.5 [72]. The role of BMP signalling in EC
proliferation is thought to be highly context dependent
[73]. Because BRE::gfp signals peaked around midgesta-
tion and progressively decreased in postnatal stages in
the vascular tree, we reasoned that correlations between
BMP-SMAD transcriptional output and proliferation
may become apparent in specific vascular beds. Remark-
ably, we found that proliferating pH3-positive ECs were
almost invariably GFP-negative in the different vascular
beds analysed, except in the P10 retina where more
often double positive cells were observed.
A recurrent theme was - like in zebrafish embryos
[74] - that the abundance of GFP-positive ECs was
higher in veins than in arteries in several embryonic and
postnatal tissues. For instance, the ECs in the cardinal
vein showed a continuous GFP localisation pattern,
whereas the aorta had a mosaic GFP pattern. In the
mesentery almost no GFP-positive ECs were observed in
the arteries, yet some of its peri-endothelial cells were
GFP-positive. In contrast, many ECs of the veins were
GFP-positive. ALK1, Endoglin and BMPR2 play a role in
the establishment and maintenance of mural cell cover-
age on mature vessels [75, 76], primarily in arteries. Mu-
tations in BMPR2 lead to PAH which is characterized by
abnormal proliferation of ECs and smooth muscle cells
(SMCs) in arterioles [73, 77], whereas a deletion of
BMPR2 leads to insufficient recruitment and decreases
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PDGFRβ expression in mural cells [77]. BMP2/BMPR2
signalling negatively regulates PDGFBB induced prolifer-
ation of pulmonary arterial SMCs in a pSMAD1/5/9 in-
dependent manner [77]. It is likely that veins express
more BMP2 and hence limit the number of SMC cover-
age, but also the differences in shear stress in both vessel
types may underlie the above differences.
Conclusion
We experienced that the BRE::gfp reporter is an exquis-
itely useful tool to get grip on the complex BMP-SMAD
transcriptional signalling contexts in vivo. The GFP signals
are robust, reproducible and highly regionalised; they cor-
relate well with known areas of BMP signalling in the
endothelium and reveal new microdomains of BMP sig-
nalling. Our study underscores the regionalised and het-
erogeneous nature of BMP signalling in the circulatory
and lymphatic vasculature of embryos and pups, with
striking shifts in transcriptional output over time in differ-
ent endothelium types. This study highlights that extrapo-
lation of results obtained in one vascular bed to another,
or generalisation, should be done with extreme care.
Examining other BMP signalling reporters and intercross-
ing them can likely shed light on yet other facets of the
complex BMP-SMAD signalling output. Knowledge on
differential signalling output is highly valuable to better
understand the ontogeny of BMP-linked diseases and may
lead to improved disease-tailored therapies.
Additional files
Additional file 1: Table S1. List of primary antibodies and glycoprotein
stainings. Biotin amplification was only required for PROX1 detection.
The same antibody concentration was used for whole mount analysis,
paraffin sections and cryosections, unless otherwise indicated.
(PDF 226 kb)
Additional file 2: Figure S1. The BRE::gfp reporter is transcriptionally
active in a subdomain of the pSMAD1/5/9-positive endothelial cells.
(A–C) Immunodetection of SMAD1/5/9 and GFP in the AVC and OFT at
E9.5 (A), the ventricular trabeculae (B) and the cardinal vein (C) at E11.5.
DAPI is used to stain nuclei. Specificity of the pSMAD1/5/9 staining was
confirmed in control embryos (D) and endothelium-specific Smad1;
Smad5 double knockout embryos (Tie2cre+/0; Smad1fl/fl; Smad5fl/fl) (E).
Embryos were analyzed at E8.5 to circumvent the embryonic lethality of
mutant embryos at E9.5. The pSMAD1/5/9 levels were specifically
reduced in endothelium of the EC-specific Smad1; Smad5 double knock-
outs, while levels remained unchanged in the non-endothelial cells. The
myocardium was visualized by an anti-MF20 staining. Arrows indicate
pSMAD1/5/9 deficient endothelium (E). At: atrium; AVC: atrioventricular
canal; CV: cardinal vein; OFT: outflow tract. Scale bars: 100 μm (A–B;D–E);
50 μm (C). (PDF 2307 kb)
Additional file 3: Figure S2. BRE::gfp localisation patterns in the P10
retina. (A–D) Immunodetection of Endomucin and GFP in the retina at
P10. The retina has a multi-layered vasculature that consist of the vascular
border (A) and centre (B) of the primary plexus, the perpendicular vessels
(C) and outer plexus (D). Single staining for GFP is shown in the lower
panels. Scale bars: 75 μm. (PDF 2844 kb)
Additional file 4: Table S2. GFP localisation patterns in embryonic
hearts with emphasis on BRE::gfp activity in endocardial cells. The number
of hearts analysed is indicated in the top row. Results are consistent for
all hearts analysed, unless specifically indicated. (C) Continuous (100 %);
(U) Ubiquitous (>70 %); (M) Mosaic (10–70 %); (O) Occasional cell (<10 %);
(P) Patches; (ND) undetectable; N/A not applicable (PDF 215 kb)
Additional file 5: Figure S3. BRE::gfp transcriptional activity in the
outflow tract and aortic and pulmonary valves. Transverse sections of
E11.5 embryos with (immuno) detection of Isolectin B4 and GFP. DAPI is
used to stain nuclei. (A) Ubiquitous GFP signal in the inflow tract valve,
and mosaic GFP localisation in the aortic (B) and pulmonary (C) valve.
Scale bars: 50 μm (PDF 181 kb)
Additional file 6: Figure S4. BRE::gfp transcriptional activity is similar in
blood and lymphatic vessels. Transverse sections through the neck of
E12.5 (A) and E14.5 (B) BRE::gfp embryos immunostained for GFP,
Endomucin, PROX1 and DAPI. Boxed areas are enlarged in the right
panels with the single GFP staining next to it. (C) Schematic overview
shows the dorsal skin area taken from an E14.5 embryo. Scale bars:
50 μm (A-B, left panels); 25 μm (A–B, right panels). (PDF 136 kb)
Additional file 7: Figure S5. BRE::gfp transcriptional activity is not
restricted to vessels. E14.5 skin biopsies with immunodetection of GFP,
PROX1 and the extracellular matrix marker Collagen type IV. Boxed areas
are enlarged in the right panels. Arrows show non-vessel structures. Scale
bars: 75 μm (left panels); 25 μm (right panels). (PDF 184 kb)
Additional file 8: Figure S6. BRE::gfp transcriptional activity does not
co-localise with Ki67 in ECs. (A) Skin biopsy of an E14.5 BRE::gfp mouse
with immunodetection of GFP, pH3 and PROX1. The merged stack in the
left panel is split up in some single z-stacks to show pH3-positive cells be-
neath or above vessel structures (arrows). E14.5 (B) and E16.5 (C) skin bi-
opsies with immunodetection of a different proliferation marker (Ki67),
GFP and PROX1. Boxed areas are enlarged in the right panels. Ki67-
positive LECs (arrows) and blood ECs (arrowheads) can be observed. Scale
bars: 75 μm (B–C, left panels); 25 μm (A; B–C, right panels). (PDF 184 kb)
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(e) GFP: (enhanced) green fluorescent protein; A: Artery; Ao: Aorta;
At: Atrium; AVC: Atrioventricular canal; BMP: Bone morphogenetic protein;
BRE: BMP response element; BSA: Bovine serum albumin; BV: Bicuspid valve;
CV: Cardinal vein; DA: Dorsal aorta; DEPC: Diethylpyrocarbonate; dOFT: Distal
outflow tract; E: Embryonic day; EC: Endothelial cell; EndMT: Endothelial-to-
mesenchymal transition; FISH: Fluorescent in situ hybridisation;
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canal cushion; ID: Inhibitor of differentiation; ISH: In situ hybridisation;
IVS: Inter-ventricular septum; L: Lymphatic vessel; LA: Left atrium;
LEC: Lymphatic endothelial cell; LS: Lymphatic sac; LV: Left ventricle;
OCT: Optimal cutting temperature; OFT: Outflow tract; ON: Overnight;
P: Postnatal day; PAH: Pulmonary arterial hypertension; PBS: Phosphate
buffered saline; PFA: Paraformaldehyde; pH3: Phospho histone 3;
pOFT: Proximal outflow tract; pSMAD: Phosphorylated SMAD; RA: Right
atrium; RT: Room temperature; RV: Right ventricle; S: Somites; sAVC: Superior
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